CRON
Price
$2.49
Change
+$0.01 (+0.40%)
Updated
Oct 17 closing price
Capitalization
954.12M
18 days until earnings call
CWBHF
Price
$0.19
Change
+$0.01 (+5.56%)
Updated
Oct 17 closing price
Capitalization
28.32M
26 days until earnings call
Interact to see
Advertisement

CRON vs CWBHF

Header iconCRON vs CWBHF Comparison
Open Charts CRON vs CWBHFBanner chart's image
Cronos Group
Price$2.49
Change+$0.01 (+0.40%)
Volume$1.63M
Capitalization954.12M
Charlotte's Web Holdings
Price$0.19
Change+$0.01 (+5.56%)
Volume$186.9K
Capitalization28.32M
CRON vs CWBHF Comparison Chart in %
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CWBHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. CWBHF commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and CWBHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (CRON: $2.49 vs. CWBHF: $0.19)
Brand notoriety: CRON and CWBHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRON: 56% vs. CWBHF: 43%
Market capitalization -- CRON: $954.12M vs. CWBHF: $28.32M
CRON [@Pharmaceuticals: Generic] is valued at $954.12M. CWBHF’s [@Pharmaceuticals: Generic] market capitalization is $28.32M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 1 FA rating(s) are green whileCWBHF’s FA Score has 0 green FA rating(s).

  • CRON’s FA Score: 1 green, 4 red.
  • CWBHF’s FA Score: 0 green, 5 red.
According to our system of comparison, CRON is a better buy in the long-term than CWBHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while CWBHF’s TA Score has 3 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 7 bearish.
  • CWBHF’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CWBHF is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Generic) experienced а -0.80% price change this week, while CWBHF (@Pharmaceuticals: Generic) price change was +4.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

CWBHF is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($954M) has a higher market cap than CWBHF($28.3M). CWBHF YTD gains are higher at: 97.872 vs. CRON (23.267). CWBHF has higher annual earnings (EBITDA): -12.94M vs. CRON (-25.58M). CRON has more cash in the bank: 834M vs. CWBHF (15.3M). CRON has less debt than CWBHF: CRON (2.01M) vs CWBHF (63.1M). CRON has higher revenues than CWBHF: CRON (130M) vs CWBHF (50.3M).
CRONCWBHFCRON / CWBHF
Capitalization954M28.3M3,371%
EBITDA-25.58M-12.94M198%
Gain YTD23.26797.87224%
P/E Ratio49.80N/A-
Revenue130M50.3M258%
Total Cash834M15.3M5,451%
Total Debt2.01M63.1M3%
FUNDAMENTALS RATINGS
CRON vs CWBHF: Fundamental Ratings
CRON
CWBHF
OUTLOOK RATING
1..100
7673
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9199
PRICE GROWTH RATING
1..100
4636
P/E GROWTH RATING
1..100
699
SEASONALITY SCORE
1..100
9032

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRON's Valuation (67) in the Pharmaceuticals Other industry is in the same range as CWBHF (84) in the null industry. This means that CRON’s stock grew similarly to CWBHF’s over the last 12 months.

CRON's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CWBHF (100) in the null industry. This means that CRON’s stock grew similarly to CWBHF’s over the last 12 months.

CRON's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as CWBHF (99) in the null industry. This means that CRON’s stock grew similarly to CWBHF’s over the last 12 months.

CWBHF's Price Growth Rating (36) in the null industry is in the same range as CRON (46) in the Pharmaceuticals Other industry. This means that CWBHF’s stock grew similarly to CRON’s over the last 12 months.

CRON's P/E Growth Rating (6) in the Pharmaceuticals Other industry is significantly better than the same rating for CWBHF (99) in the null industry. This means that CRON’s stock grew significantly faster than CWBHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONCWBHF
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
71%
Bullish Trend 16 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
82%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CWBHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OALVX20.250.13
+0.65%
Optimum Large Cap Value A
DCUIX14.910.08
+0.54%
DWS CROCI US Inst
FCPGX35.09N/A
N/A
Fidelity Small Cap Growth
EGLNX9.93N/A
N/A
Eagle Energy Infrastructure N
RYBAX78.92-1.74
-2.16%
Rydex Basic Materials H

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+0.40%
SNDL - CRON
73%
Closely correlated
-2.10%
TLRY - CRON
65%
Loosely correlated
+1.30%
OGI - CRON
60%
Loosely correlated
-3.70%
CGC - CRON
60%
Loosely correlated
-2.96%
ACB - CRON
59%
Loosely correlated
-0.95%
More

CWBHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CWBHF has been loosely correlated with TLRY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CWBHF jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CWBHF
1D Price
Change %
CWBHF100%
+1.20%
TLRY - CWBHF
40%
Loosely correlated
+1.30%
ACB - CWBHF
35%
Loosely correlated
-0.95%
CGC - CWBHF
34%
Loosely correlated
-2.96%
CRON - CWBHF
26%
Poorly correlated
+0.40%
FLGC - CWBHF
24%
Poorly correlated
-5.29%
More